Previous close | 21.00 |
Open | 21.00 |
Bid | 20.60 x 0 |
Ask | 22.00 x 0 |
Day's range | 20.74 - 21.35 |
52-week range | 13.00 - 45.00 |
Volume | |
Avg. volume | 72,922 |
Market cap | 15.718M |
Beta (5Y monthly) | 1.14 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.08 |
Earnings date | 29 May 2024 - 03 Jun 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Oncimmune Holdings ( LON:ONC ) Full Year 2023 Results Key Financial Results Revenue: UK£1.15m (down 62% from FY 2022...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Tuesday, May 9, 2023. A total of 44% of the issued and outstanding common shares of the Corporation were represented either in person or by proxy at the meeting.
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced recent operational highlights and financial results for the first quarter ended March 31, 2023. All dollar amounts are expressed in Canadian currency unless otherwise noted.